What This Means for Your Practice: 503A Compounded Products (Patient-Specific): The enforcement discretion period has ended
As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinicallythat the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients. Although this study cannot prove a causal link between GLP-1 medication and the effects seen on the patients taking them, it opens the door to future combinations of treatments for autoimmune disease with GLP-1 drugs
Your healthier future starts with one consult
How Dosing Cadence Impacts Fullness, Hunger, And Progress The timing and consistency of your GLP-1 injections, or your dosing cadence, play a significant role in managing fullness and hunger
As of July 23, 2019, 30 patients had been enrolled, and preliminary data regarding demographics and clinical characteristics were summarized